This NDC is on FDA's drug shortage list (posted Jul 18, 2023)

Product Information

LIRAGLUTIDE 3-PAK 18 MG/3 ML is a generic product labeled by Meitheal Pharmaceuticals Inc., priced at $25.4444 per ML under NDC 71288056384. Its NADAC has been published 76 times since Jun 11, 2025.

FDA first approved this application on Apr 2, 2025. Its Orange Book therapeutic-equivalence code is AP1.

LIRAGLUTIDE 3-PAK 18 MG/3 ML

liraglutide
$25.4444per ML

Strength

6 mg/mL

NDC

71288056384

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

LIRAGLUTIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA218115

FDA Approved

4/2/2025

TE Code

AP1

On Market Since

4/2/2025

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price Statistics

The NADAC for LIRAGLUTIDE 3-PAK 18 MG/3 ML has been published 76 times since Jun 11, 2025, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.

Current price$25.4444 per ML
All-time high$60.7931 (Jun 11, 2025)
All-time low$25.4444 (Nov 18, 2026)
52-week high$51.3891
52-week low$25.4444
Median price$42.9586
Average price$43.3169
Largest weekly change-12.8% (Nov 18, 2026)
Weeks tracked76
Tracking sinceJun 11, 2025

Price History

1W

-12.8%

1M

-16.9%

3M

-20.5%

6M

-26.7%

1Y

-52.2%

3Y

N/A

5Y

N/A

All

-58.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LIRAGLUTIDE 3-PAK 18 MG/3 ML?

The current National Average Drug Acquisition Cost (NADAC) for LIRAGLUTIDE 3-PAK 18 MG/3 ML, manufactured by Meitheal Pharmaceuticals Inc., is $25.4444 per ML (NDC 71288056384), effective Nov 18, 2026.

How has the price of LIRAGLUTIDE 3-PAK 18 MG/3 ML changed over time?

Over the history we have for it, the NADAC for LIRAGLUTIDE 3-PAK 18 MG/3 ML has declined 58.1%. It has been tracked across 76 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for LIRAGLUTIDE 3-PAK 18 MG/3 ML?

Since Jun 11, 2025, the NADAC for LIRAGLUTIDE 3-PAK 18 MG/3 ML has ranged from a low of $25.4444 (Nov 18, 2026) to a high of $60.7931 (Jun 11, 2025), with a median of $42.9586 per ML.

Are there cheaper alternatives to LIRAGLUTIDE 3-PAK 18 MG/3 ML?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIRAGLUTIDE 3-PAK 18 MG/3 ML in a comparable dosage form, but none are currently priced below it.

Who manufactures LIRAGLUTIDE 3-PAK 18 MG/3 ML?

LIRAGLUTIDE 3-PAK 18 MG/3 ML (NDC 71288056384) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a generic product.

Is LIRAGLUTIDE 3-PAK 18 MG/3 ML in shortage?

Yes — NDC 71288056384 is currently listed in FDA's drug shortage database (posted Jul 18, 2023).